Patrick A. Kwaah, M., Samuel A. Mensah, M., Abraham Carboo, M., Hamza A. Rashid, M., Emmanuel A. Agyemang, M., Grace Appah, M., & Smith K. Frimpong, M. Cardiovascular Outcomes of Semaglutide vs Dulaglutide in Nonobese Type II Diabetes Patients With HFpEF. Elsevier.
Chicago Style (17th ed.) CitationPatrick A. Kwaah, MBChB, MBChB Samuel A. Mensah, MBChB Abraham Carboo, MBBS Hamza A. Rashid, MBChB Emmanuel A. Agyemang, MBChB Grace Appah, and MD Smith K. Frimpong. Cardiovascular Outcomes of Semaglutide Vs Dulaglutide in Nonobese Type II Diabetes Patients With HFpEF. Elsevier.
MLA (9th ed.) CitationPatrick A. Kwaah, MBChB, et al. Cardiovascular Outcomes of Semaglutide Vs Dulaglutide in Nonobese Type II Diabetes Patients With HFpEF. Elsevier.
Warning: These citations may not always be 100% accurate.